Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

NCT05264974 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Florida

Collaborators